D
A. R. Kosso et al.
Letter
Synlett
References and Notes
(7) (a) Reis, J.; Gaspar, A.; Milhazes, N.; Borges, F. J. Med. Chem.
2017, 60, 7941. (b) Gaspar, A.; Matos, M. J.; Garrido, J.; Uriarte,
E.; Borges, F. Chem. Rev. 2014, 114, 4960.
(8) (a) Zhong, S.; Liu, Y.; Cao, X.; Wan, J.-P. ChemCatChem 2017, 9,
465. (b) Joussot, J.; Schoenfelder, A.; Larquetoux, L.; Nicolas, M.;
Suffert, J.; Blond, G. Synthesis 2016, 48, 3364.
(1) (a) Baquedano, Y.; Moreno, E.; Espuelas, S.; Nguewa, P.; Font,
M.; Gutierrez, K. J.; Jiménez-Ruiz, A.; Palop, J. A.; Sanmartín, C.
Eur. J. Med. Chem. 2014, 74, 116. (b) Baquedano, Y.; Alcolea, V.;
Toro, M. A.; Gutierrez, K. J.; Nguewa, P.; Font, M.; Moreno, E.;
Espuelas, S.; Jimenez-Ruiz, A.; Palop, J. A.; Plano, D.; Sanmartín,
C. Antimicrob. Agents Chemother. 2016, 60, 3802.
(2) (a) Facompre, N. D.; El-Bayoumy, K.; Sun, Y.-W.; Pinto, J. T.;
Sinha, R. Cancer Prev. Res. 2010, 3, 975. (b) Sohn, O. S.; Fiala, E.
S.; Upadhyaya, P.; Chae, Y. H.; El-Bayoumy, K. Carcinogenesis
1999, 20, 615.
(3) (a) Nikolaienko, P.; Rueping, M. Chem. Eur. J. 2016, 22, 2620.
(b) Mukherjee, N.; Kundu, D.; Ranu, B. C. Adv. Synth. Catal. 2017,
359, 329. (c) Maity, P.; Paroi, B.; Ranu, B. C. Org. Lett. 2017, 19,
5748. (d) Krief, A.; Dumont, W.; Delmotte, C. Angew. Chem. Int.
Ed. 2000, 39, 1669.
(4) (a) Vijay, N.; Anu, A.; Tesmol, G. G. Eur. J. Org. Chem. 2002, 2363.
(b) Chen, J.; Wang, T.; Wang, T.; Lin, A.; Yao, H.; Xu, J. Org. Chem.
Front. 2017, 4, 130. (c) Muniraj, N.; Dhineshkumar, J.; Prabhu, K.
R. Chemistry Select 2016, 1, 1033. (d) Zhang, H.; Wei, Q.; Wei, S.;
Qu, J.; Wang, B. Eur. J. Org. Chem. 2016, 20, 3373.
(9) For a similar one-pot procedure from o-hydroxyacetophenone
via enaminone species, see: Zhang, X.-Z.; Ge, D.-L.; Chen, S.-Y.;
Yu, X.-Q. RSC Adv. 2016, 6, 66320. For one-pot procedure from
enaminone species, see: Rafique J., Saba S., Schneider A. R.,
Franco M. S., Silva S. M., Braga A. L. ACS Omega; 2017, 2: 2280.
(10) 3-Selenocyanato-4H-chromen-4-ones 3; General Procedure:
A mixture of o-hydroxyacetophenone (1a; 136 mg, 1 mmol,
1 equiv) and dimethylformamide dimethylacetal (120 mg,
1 mmol, 1 equiv) was heated for 2 h at 100 °C. After cooling to
25 °C, a preprepared solution of malononitrile (66 mg, 1 mmol,
1 equiv) and SeO2 (332 mg, 3 mmol, 3 equiv) in DMSO (1 mL),
stirred at 25 °C for 20 min, was added at 25 °C. The reaction
mixture was stirred for a further 30 min, then H2O was added
(3 mL). The resulting precipitate was filtered off, washed with
H2O (3 × 10 mL) and dried under a fume hood overnight at 25 °C
to give the pure product 3a.
(5) For the first synthesis, see: (a) Verneuil, A. Ann. Chim. Phys.
1886, 41, 328. For crystal data, see: (b) Aksnes, O.; Foss, O. Acta
Chem. Scand. 1954, 1787. (c) Hauge, S. Acta Chem. Scand. 1971,
25, 3081. (d) Burchell, C. J.; Kilian, P.; Slawin, A. M. Z.; Woollins,
J. D.; Tersago, K.; Van Alsenoy, C.; Blockhuys, F. Inorg. Chem.
2006, 45, 710.
(6) (a) Kachanov, A. V.; Slabko, O. Y.; Baranova, O. V.; Shilova, E. V.;
Kaminskii, V. A. Tetrahedron Lett. 2004, 45, 4461. (b) Redon, S.;
Obah Kosso, A. R.; Broggi, J.; Vanelle, P. Tetrahedron Lett. 2017,
58, 2771. (c) Redon, S.; Kabri, Y.; Crozet, M. D.; Vanelle, P. Tetra-
hedron Lett. 2014, 55, 5052.
3-Selenocyanato-4H-chromen-4-one (3a): brown solid; yield:
76%; mp 136–137 °C. 1H NMR (250 MHz, CDCl3): δ = 8.26 (s,
1 H), 8.20 (dd, J = 8.0, 1.6 Hz, 1 H), 7.79 (dt, J = 8.4, 1.7 Hz, 1 H),
7.56 (dt, J = 8.4 Hz, 1 H), 7.51 (dt, J = 7.1, 1.1 Hz, 1 H). 13C NMR
(62.5 MHz, CDCl3): δ = 174.3 (CO), 156.7 (C), 153.1 (CH), 135.1
(CH), 126.5 (CH), 125.9 (CH), 122.0 (C), 118.6 (CH), 112.7 (C),
100.0 (CN). HRMS (ESI): m/z [M + H]+ calcd for C10H5NO2Se:
251.9559; found: 251.9557.
(11) Redon, S.; Pannecoucke, X.; Franck, X.; Outurquin, F. Org.
Biomol. Chem. 2008, 6, 1260.
(12) (a) ten Brink, G.-J.; Vis, J.-M.; Arends, I. W. C. E.; Sheldon, R. A.
J. Org. Chem. 2001, 66, 2429. (b) Zhang, X.; Ye, J.; Yu, L.; Shi, X.;
Zhang, M.; Xu, Q.; Lautens, M. Adv. Synth. Catal. 2015, 357, 955.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2018, 29, A–D